Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome

Abstract Primary Sjögren’s syndrome is an autoimmune disease characterized by dry eye and dry mouth. We systematically reviewed all the randomized controlled clinical trials published in the last 15 years that included ocular outcomes. We found 22 trials involving 9 topical, 10 oral, 2 intravenous a...

Full description

Bibliographic Details
Main Authors: Kendrick Co Shih, Christie Nicole Lun, Vishal Jhanji, Bernard Yu-Hor Thong, Louis Tong
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Journal of Inflammation
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12950-017-0174-3
_version_ 1819264404153171968
author Kendrick Co Shih
Christie Nicole Lun
Vishal Jhanji
Bernard Yu-Hor Thong
Louis Tong
author_facet Kendrick Co Shih
Christie Nicole Lun
Vishal Jhanji
Bernard Yu-Hor Thong
Louis Tong
author_sort Kendrick Co Shih
collection DOAJ
description Abstract Primary Sjögren’s syndrome is an autoimmune disease characterized by dry eye and dry mouth. We systematically reviewed all the randomized controlled clinical trials published in the last 15 years that included ocular outcomes. We found 22 trials involving 9 topical, 10 oral, 2 intravenous and 1 subcutaneous modalities of treatment. Fluoromethalone eye drops over 8 weeks were more effective than topical cyclosporine in the treatment of dry eye symptoms and signs; similarly, indomethacin eye drops over 1 month were more efficacious than diclofenac eye drops. Oral pilocarpine 5 mg twice daily over 3 months was superior to use of lubricants or punctal plugs for treating dry eye, but 5% of participants had gastrointestinal adverse effects from pilocarpine, though none discontinued treatment. In contrast, etanercept, a TNF-alpha blocking antibody, administered as subcutaneous injections twice weekly, did not improve dry eye significantly compared to placebo injections. In conclusion, topical corticosteroids have been shown to be effective in dry eye associated with Sjögren’s syndrome. As some topical non-steroidal anti-inflammatory drugs may be more effective than others, these should be further evaluated. Systemic secretagogues like pilocarpine have a role in Sjögren’s syndrome but the adverse effects may limit their clinical use. It is disappointing that systemic cytokine therapy did not produce encouraging ocular outcomes but participants should have assessment of cytokine levels in such trials, as those with higher baseline cytokine levels may respond better. (229 words)
first_indexed 2024-12-23T20:28:56Z
format Article
id doaj.art-da729c720cd741a6bffe0db21706d4c3
institution Directory Open Access Journal
issn 1476-9255
language English
last_indexed 2024-12-23T20:28:56Z
publishDate 2017-11-01
publisher BMC
record_format Article
series Journal of Inflammation
spelling doaj.art-da729c720cd741a6bffe0db21706d4c32022-12-21T17:32:19ZengBMCJournal of Inflammation1476-92552017-11-0114111110.1186/s12950-017-0174-3Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndromeKendrick Co Shih0Christie Nicole Lun1Vishal Jhanji2Bernard Yu-Hor Thong3Louis Tong4Department of Ophthalmology, Li Ka Shing Faculty of Medicine, University of Hong KongLi Ka Shing Faculty of Medicine, University of Hong KongDepartment of Ophthalmology, University of Pittsburgh Medical CentreDepartment of Rheumatology, Allergy and Immunology, Tan Tock Seng HospitalOcular Surface Research Group, Singapore Eye Research InstituteAbstract Primary Sjögren’s syndrome is an autoimmune disease characterized by dry eye and dry mouth. We systematically reviewed all the randomized controlled clinical trials published in the last 15 years that included ocular outcomes. We found 22 trials involving 9 topical, 10 oral, 2 intravenous and 1 subcutaneous modalities of treatment. Fluoromethalone eye drops over 8 weeks were more effective than topical cyclosporine in the treatment of dry eye symptoms and signs; similarly, indomethacin eye drops over 1 month were more efficacious than diclofenac eye drops. Oral pilocarpine 5 mg twice daily over 3 months was superior to use of lubricants or punctal plugs for treating dry eye, but 5% of participants had gastrointestinal adverse effects from pilocarpine, though none discontinued treatment. In contrast, etanercept, a TNF-alpha blocking antibody, administered as subcutaneous injections twice weekly, did not improve dry eye significantly compared to placebo injections. In conclusion, topical corticosteroids have been shown to be effective in dry eye associated with Sjögren’s syndrome. As some topical non-steroidal anti-inflammatory drugs may be more effective than others, these should be further evaluated. Systemic secretagogues like pilocarpine have a role in Sjögren’s syndrome but the adverse effects may limit their clinical use. It is disappointing that systemic cytokine therapy did not produce encouraging ocular outcomes but participants should have assessment of cytokine levels in such trials, as those with higher baseline cytokine levels may respond better. (229 words)http://link.springer.com/article/10.1186/s12950-017-0174-3Dry eyeSystematic reviewRandomized controlled trialsSjögren’s syndromeKeratoconjunctivitis sicca
spellingShingle Kendrick Co Shih
Christie Nicole Lun
Vishal Jhanji
Bernard Yu-Hor Thong
Louis Tong
Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome
Journal of Inflammation
Dry eye
Systematic review
Randomized controlled trials
Sjögren’s syndrome
Keratoconjunctivitis sicca
title Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome
title_full Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome
title_fullStr Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome
title_full_unstemmed Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome
title_short Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome
title_sort systematic review of randomized controlled trials in the treatment of dry eye disease in sjogren syndrome
topic Dry eye
Systematic review
Randomized controlled trials
Sjögren’s syndrome
Keratoconjunctivitis sicca
url http://link.springer.com/article/10.1186/s12950-017-0174-3
work_keys_str_mv AT kendrickcoshih systematicreviewofrandomizedcontrolledtrialsinthetreatmentofdryeyediseaseinsjogrensyndrome
AT christienicolelun systematicreviewofrandomizedcontrolledtrialsinthetreatmentofdryeyediseaseinsjogrensyndrome
AT vishaljhanji systematicreviewofrandomizedcontrolledtrialsinthetreatmentofdryeyediseaseinsjogrensyndrome
AT bernardyuhorthong systematicreviewofrandomizedcontrolledtrialsinthetreatmentofdryeyediseaseinsjogrensyndrome
AT louistong systematicreviewofrandomizedcontrolledtrialsinthetreatmentofdryeyediseaseinsjogrensyndrome